These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17055188)

  • 1. Therapeutic potential of Rho-kinase inhibitors in asthma.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Med Hypotheses; 2007; 68(3):705-6. PubMed ID: 17055188
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternatives to Viagra.
    Weitzman J
    Trends Mol Med; 2001 Mar; 7(3):102. PubMed ID: 11286776
    [No Abstract]   [Full Text] [Related]  

  • 3. Rho-kinase inhibitor may exert a role in preventing cardiac hypertrophy, independent of antihypertensive effects.
    Pan M; Jing HM; Zhu JH; Liu ZH; Jiang WP; Yang XJ
    Med Hypotheses; 2007; 68(1):234. PubMed ID: 16919397
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of tonic contraction--a novel way to approach erectile dysfunction.
    Mills TM; Lewis RW; Wingard CJ; Chitaley K; Webb RC
    J Androl; 2002; 23(5):S5-9. PubMed ID: 12236171
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction.
    Schaafsma D; Bos IS; Zuidhof AB; Zaagsma J; Meurs H
    Respir Res; 2006 Sep; 7(1):121. PubMed ID: 17002806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.
    Fernandes LB; Henry PJ; Goldie RG
    Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho kinase as a novel molecular therapeutic target for hypertensive internal anal sphincter.
    Rattan S; De Godoy MA; Patel CA
    Gastroenterology; 2006 Jul; 131(1):108-16. PubMed ID: 16831595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho kinase: a target for treating urinary bladder dysfunction?
    Peters SL; Schmidt M; Michel MC
    Trends Pharmacol Sci; 2006 Sep; 27(9):492-7. PubMed ID: 16870270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of 4-(1-aminoalkyl)-N-(4-pyridyl)cyclohexanecarboxamides as Rho kinase inhibitors and neurite outgrowth promoters.
    Gingras K; Avedissian H; Thouin E; Boulanger V; Essagian C; McKerracher L; Lubell WD
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4931-4. PubMed ID: 15341954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress in study of mechanism of invasion and metastasis of hepatocellular carcinoma].
    Takamura M; Sakamoto M; Hirohashi S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():169-75. PubMed ID: 11761936
    [No Abstract]   [Full Text] [Related]  

  • 11. Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome.
    Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A; Pessina AC
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):e34; author reply e34-5. PubMed ID: 15790936
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-kinase inhibitors: potential therapeutics for benign prostate hyperplasia.
    Adam R
    J Urol; 2003 Dec; 170(6 Pt 1):2523-4. PubMed ID: 14634464
    [No Abstract]   [Full Text] [Related]  

  • 15. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice.
    Büyükafşar K; Yalçin I; Kurt AH; Tiftik RN; Sahan-Firat S; Aksu F
    Eur J Pharmacol; 2006 Jul; 541(1-2):49-52. PubMed ID: 16750189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Signal transduction and therapeutic strategies].
    Narumiya S
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):827-32. PubMed ID: 10771640
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors.
    Goodman KB; Cui H; Dowdell SE; Gaitanopoulos DE; Ivy RL; Sehon CA; Stavenger RA; Wang GZ; Viet AQ; Xu W; Ye G; Semus SF; Evans C; Fries HE; Jolivette LJ; Kirkpatrick RB; Dul E; Khandekar SS; Yi T; Jung DK; Wright LL; Smith GK; Behm DJ; Bentley R; Doe CP; Hu E; Lee D
    J Med Chem; 2007 Jan; 50(1):6-9. PubMed ID: 17201405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.
    Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of Rho kinase inhibitors (II).
    Iwakubo M; Takami A; Okada Y; Kawata T; Tagami Y; Ohashi H; Sato M; Sugiyama T; Fukushima K; Iijima H
    Bioorg Med Chem; 2007 Jan; 15(1):350-64. PubMed ID: 17046269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation.
    Pandey D; Goyal P; Siess W
    Blood Cells Mol Dis; 2007; 38(3):269-79. PubMed ID: 17321765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.